Who Paid My Doc
Nicholas Pokrajac
Pediatric Emergency Medicine Stanford, CA Medical Doctor
NPI 1770920936 CMS profile 2780592
300 Pasteur Dr, Stanford, CA 94305
General payments
$12
Research payments
$0
Ownership & investment interest
$0
Through program year 2019, Nicholas Pokrajac of Stanford, CA is reported in the CMS Open Payments database as having received $12 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 1st percentile of Pediatric Emergency Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2019 | General | $12 | 1 |
Beside peers
- Nicholas Pokrajac
- Pediatric Emergency Medicine median
- Middle half of Pediatric Emergency Medicine
- National median
In program year 2025, general payments to Nicholas Pokrajac were reported at $0. Among 93 Pediatric Emergency Medicine profiles paid that year, the median was $58 and the middle half received between $26 and $151.
Show as a table
| Year | Nicholas Pokrajac | Pediatric Emergency Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $12 | $62 | $20–$135 | $163 |
| 2020 | $0 | $37 | $19–$129 | $114 |
| 2021 | $0 | $52 | $17–$103 | $132 |
| 2022 | $0 | $89 | $25–$138 | $149 |
| 2023 | $0 | $52 | $25–$157 | $160 |
| 2024 | $0 | $85 | $24–$156 | $164 |
| 2025 | $0 | $58 | $26–$151 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 18 billing codesPaid by Medicare
$17,291
Medicare patients
122
Services billed
147
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Chronic kidney disease | 41% | |
| Ischemic heart disease | 40% | |
| Arthritis | 39% | |
| Diabetes | 34% | |
| Heart failure | 34% | |
| Atrial fibrillation | 33% | |
| Cancer | 31% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Emergency Medicine in California
Shyam Sivasankar
Pediatric Emergency Medicine · Stanford, CA
Michael Bell
Pediatric Emergency Medicine · Oakland, CA
Jon Detterich
Pediatric Emergency Medicine · Los Angeles, CA
Neelam Patel
Pediatric Emergency Medicine · Los Angeles, CA
Hrach Arutyunyan
Pediatric Emergency Medicine · Glendale, CA
Issac Jakubowicz
Pediatric Emergency Medicine · Los Angeles, CA
Related records
Pediatric Emergency Medicine in California
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Emergency Medicine
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.